PET for in vivo pharmacokinetic and pharmacodynamic measurements.
about
Molecular imaging: spawning a new melting-pot for biomedical imaging.Microdialysis versus other techniques for the clinical assessment of in vivo tissue drug distribution.Quantitative accuracy of PET/CT for image-based kinetic analysis.Design and optimization of coin-shaped microreactor chips for PET radiopharmaceutical synthesisMolecular imaging in oncology.Imaging and cancer: a review.Big physics, small doses: the use of AMS and PET in human microdosing of development drugs.Translational molecular imaging for cancer.Photodegradation of antibiotic 5-sulfaminouracil in the presence of vitamin B2: a kinetic study.The potential of positron-emission tomography to study anticancer-drug resistance.Molecular imaging in vivo: an introduction.Chemical Conjugation of Evans Blue Derivative: A Strategy to Develop Long-Acting Therapeutics through Albumin Binding.The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trialsAlpha-v integrins as therapeutic targets in oncology.The current role of PET-CT in the characterization of hepatobiliary malignancies.New ultrasensitive detection technologies and techniques for use in microdosing studies.The evolution of imaging in cancer: current state and future challenges.Fluorinase: a tool for the synthesis of ¹⁸F-labeled sugars and nucleosides for PET.Understanding the pharmacokinetics of tulathromycin: a pulmonary perspective.Intratumor heterogeneity and its impact on drug distribution and sensitivity.The synthesis of 64Cu-chelated porphyrin photosensitizers and their tumor-targeting peptide conjugates for the evaluation of target cell uptake and PET image-based pharmacokinetics of targeted photodynamic therapy agents.In Vivo Measurements of Tumor Metabolism and Growth after Administration of Enzastaurin Using Small Animal FDG Positron Emission Tomography.Pulmonary pharmacokinetics of tulathromycin in swine. Part 2: Intra-airways compartments.Evaluation of objective functions for estimation of kinetic parameters.
P2860
Q30475428-7AA5E093-588C-4B5B-84CB-0324F93B42F7Q31046210-68AC169C-48CE-4271-A535-59738381270DQ33603720-505C71FD-255E-4E43-B884-E0B8BB5E8D9AQ34397455-A35D2613-0A29-467B-9005-A32CF7B194E0Q34533365-098505FA-13D3-4FAA-BD5D-99BE12AE549EQ34977050-362A57D0-7633-48A3-88A2-D733E5849697Q35075780-D56106FE-AEB0-4BFF-8C64-D84C89471722Q35173093-FB56A5B0-D2B2-4BBC-B343-5CBCD4F0701DQ35232320-5A3B539A-DC40-46BA-87B4-2B2868098FFDQ35788120-37C68051-EEA0-4501-BD40-3B4DE4A73A89Q35968130-96E9A166-C100-40BE-9776-796D90A31DF6Q36510864-FA35A053-18D1-4E4D-80EF-8BCD62FDD99BQ36611045-CA9FEAFD-902D-4FAB-99AF-F821C05A709BQ37008623-7B3A8E74-B2D5-470F-AB7F-8CEEEB9F9120Q37546832-D7D8AB40-918A-4CFC-B421-D5E749EA90E5Q37810198-25819DE6-E08A-4DCF-88E8-EBDA9B0FC436Q37848518-51AEE31F-E55F-4EFD-A8E7-295CA3D3E0EDQ37855878-117DBEDB-44EC-4B88-887F-94C8AE8384CAQ38151858-B1006862-1064-41C6-899A-2D12992E80A5Q38211694-9FB7FC6E-19BF-47CD-A7DA-0088269CC64BQ39162754-9C4A05BE-A87F-4D4F-971E-84DD07F56D90Q39841564-7AC35E47-A858-4195-8147-D400561B5A42Q46490969-2943A5B8-A9D1-4E64-95BA-B6C5B4267254Q46987794-DEC903D4-8BA2-4FE3-89E2-83A7D5FAB5A0
P2860
PET for in vivo pharmacokinetic and pharmacodynamic measurements.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
PET for in vivo pharmacokinetic and pharmacodynamic measurements.
@ast
PET for in vivo pharmacokinetic and pharmacodynamic measurements.
@en
PET for in vivo pharmacokinetic and pharmacodynamic measurements.
@nl
type
label
PET for in vivo pharmacokinetic and pharmacodynamic measurements.
@ast
PET for in vivo pharmacokinetic and pharmacodynamic measurements.
@en
PET for in vivo pharmacokinetic and pharmacodynamic measurements.
@nl
prefLabel
PET for in vivo pharmacokinetic and pharmacodynamic measurements.
@ast
PET for in vivo pharmacokinetic and pharmacodynamic measurements.
@en
PET for in vivo pharmacokinetic and pharmacodynamic measurements.
@nl
P2093
P1476
PET for in vivo pharmacokinetic and pharmacodynamic measurements.
@en
P2093
P304
P356
10.1016/S0959-8049(02)00413-6
P577
2002-11-01T00:00:00Z